Cowen Reiterates Outperform on Applied Materials (AMAT) Following In-Line 4Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- Netflix raises prices in Germany and Austria, Citi comments
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Nomura Sees Applied Materials (AMAT) as a Great Value Name
November 16, 2015 8:01 AM ESTNomura analyst, Romit Shah, believes investors are preoccupied about how Applied Materials (NASDAQ: AMAT) will respond to Lam Research, and underappreciating an attractive return profile that should improve over the next three years. Today, the company offers 9% FCF yield and mid-teens growth but could grow into double... More
UBS Remains Neutral on Applied Materials (AMAT) Following 3Q Results
November 13, 2015 9:33 AM ESTUBS reiterated a Neutral rating on Applied Materials (NASDAQ: AMAT), and raised the price target to $18.00 (from $15.75), following the company's 3Q earnings report. Applied's Oct-15 results were in-line with its guidance despite its semicap orders being down 28% q/q. A key focus has been gross margin trends and... More
Needham More Cautious than Applied Materials' (AMAT) Management
November 13, 2015 8:00 AM ESTApplied Materials (NASDAQ: AMAT) reported a largely inline F4Q15 (Oct) but provided better than expected F1Q15 (Jan) earnings outlook on good cost control. Management's outlook calls for CY16 WFE to be flat to CY15 based on a recovery in CY2H16. However, Needham & Company... More
After-Hours Movers 11/12: (LPCN) (BUFF) (YUM) (CWEI) Higher; (JWN) (PRTY) (FOSL) (CSCO) Lower (more...)
November 12, 2015 6:36 PM ESTNordstrom (NYSE: JWN) 20% LOWER; reported Q3 EPS of $0.42, may not compare the analyst estimate of $0.72. (This included a reduction in earnings per diluted share of $0.15, which primarily represented transaction costs associated with the closing of its credit card portfolio sale.) Revenue for the quarter came in at $3.2 billion versus the consensus estimate of $3.37 billion. The Company said its third quarter performance was below Company expectations, reflecting softer sales trends that were generally consistent across channels and merchandise categories. Total Company net sales increased 6.6 percent and comparable sales increased... More
Applied Materials (AMAT) Reports In-Line Q4 EPS, Guides Q1 EPS In-Line
November 12, 2015 4:11 PM ESTApplied Materials (NASDAQ: AMAT) reported Q4 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $2.42 billion versus the consensus estimate of $2.4 billion.
Applied Materials sees Q1 2016 EPS of $0.23-$0.27, versus the consensus of $0.25.
Applied... MoreTrading Radar for 11/12: Cisco (CSCO), Viacom (VIAB), Himax (HIMX), Planet Fitness (PLNT), Fossil (FOSL) Report
November 11, 2015 3:47 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
500.com Ltd. (NYSE: WBAI) - consensus loss $0.07
AdCare Health Systems (NYSE: ADK) - no Street consensus
Advance Auto Parts (NYSE: AAP) - consensus EPS $2.09
Air Industries Group (NYSE: AIRI) - consensus EPS $0.09
Aldeyra Therapeutics (Nasdaq:... More

